David Englert
Chief Tech/Sci/R&D Officer at Axela, Inc.
Profile
David Englert is currently the Head of Research & Development at Axela, Inc. He previously worked as a Researcher at Pharmacia LKB Biotechnology, Inc. Dr. Englert holds a doctorate degree from The State University of New York.
David Englert active positions
Companies | Position | Start |
---|---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | 2011-08-29 |
Former positions of David Englert
Companies | Position | End |
---|---|---|
Pharmacia LKB Biotechnology, Inc. | Corporate Officer/Principal | - |
Training of David Englert
The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Pharmacia LKB Biotechnology, Inc. |
- Stock Market
- Insiders
- David Englert